Catheter Precision, Inc. VTAK
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 135.88% | 81.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 135.88% | 81.51% | |||
| Cost of Revenue | 2,092.86% | 110.00% | |||
| Gross Profit | -74.87% | 78.90% | |||
| SG&A Expenses | 52.83% | -7.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 80.87% | -11.40% | |||
| Operating Income | -70.62% | 19.12% | |||
| Income Before Tax | -93.99% | 69.23% | |||
| Income Tax Expenses | -78.29% | 18.22% | |||
| Earnings from Continuing Operations | -95.62% | 71.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 22.22% | -87.14% | |||
| Net Income | -96.01% | 70.91% | |||
| EBIT | -70.62% | 19.12% | |||
| EBITDA | -86.77% | 18.21% | |||
| EPS Basic | 33.46% | 59.29% | |||
| Normalized Basic EPS | -65.78% | -132.37% | |||
| EPS Diluted | 33.46% | 59.29% | |||
| Normalized Diluted EPS | -65.78% | -132.37% | |||
| Average Basic Shares Outstanding | 26.26% | 29.26% | |||
| Average Diluted Shares Outstanding | 26.26% | 29.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||